TIDMHIK

RNS Number : 5610L

Hikma Pharmaceuticals Plc

06 September 2019

Notification and public disclosure of transactions by person discharging managerial responsibilities

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Disposal of 150,000 Ordinary Shares of 10 pence 
       transaction               each in Hikma Pharmaceuticals PLC by Banque 
                                 Lombard Odier & Cie SA 
 c)   Price(s) and              Price(s): GBP20.56 
       volume(s)                 Volume(s): 49,826 
                                 Price(s): GBP19.85 
                                 Volume(s): 25,000 
                                 Price(s): GBP19.82 
                                 Volume(s): 25,000 
                                 Price(s): GBP19.84 
                                 Volume(s): 25,000 
                                 Price(s): GBP19.82 
                                 Volume(s): 25,174 
 d)   Aggregated information    Aggregated volume: 150,000 
                                 Price: GBP20.07 
                                 Total: GBP3,011,121 
 e)   Date of the transaction   4 and 6 September 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction

Peter Speirs, Company Secretary, Responsible for releasing this announcement

6 September 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBSGDCXDGBGCL

(END) Dow Jones Newswires

September 06, 2019 10:25 ET (14:25 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Hikma Pharmaceuticals